ANDROGEN, ESTROGEN, AND PROGESTERONE-RECEPTOR CONTENTS AND SERUM HORMONE PROFILES IN PATIENTS WITH BENIGN HYPERTROPHY AND CARCINOMA OF THE PROSTATE

被引:30
作者
KUMAR, VL
WADHWA, SN
KUMAR, V
FAROOQ, A
机构
[1] ALL INDIA INST MED SCI, DEPT UROL, NEW DELHI 110029, INDIA
[2] ALL INDIA INST MED SCI, DEPT REPROD BIOL, NEW DELHI 110029, INDIA
[3] ALL INDIA INST MED SCI, DEPT REPROD BIOL, NEW DELHI 110029, INDIA
[4] SHAHID JEET SINGH MARG, INT CTR GENET ENGN & BIOTECHNOL, NEW DELHI, INDIA
关键词
prostate cancer; serum hormones; steroid receptors;
D O I
10.1002/jso.2930440213
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytosolic and nuclear androgen, estrogen and progesterone receptor content was measured in the groups of 11 prostatic carcinoma (PCA) and 32 benign prostatic hypertrophy (BPH) samples. All BPH cases were positive for the cytosolic progesterone (PRc) and estrogen receptor (ERc), whereas only 85% of cases (23/27) contained the androgen receptor (ARc). Only those five patients who received estrogen treatment in the PCA group had detectable ARc. PRc was present in all of the PCA cases, whereas ERc could be detected in only 82% (9/11) of cases. Cytosolic contents of all three steroid receptors, however, were higher in the PCA group. The level of nuclear steroid receptors, although present in fewer cases in both groups, was higher than the cytoplasmic receptors. The serum profile of estradiol, cortisol, and prolactin was normal in both groups, whereas LH, FSH, and progesterone levels were higher than in normal adults. Serum testosterone level was within normal range in the BPH group, but it was significantly below normal (P < 0.005) in PCA patients. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:122 / 128
页数:7
相关论文
共 40 条
[1]   CHARACTERIZATION AND MEASUREMENT OF CYTOPLASMIC AND NUCLEAR ESTRADIOL-17-BETA-RECEPTOR PROTEINS IN BENIGN HYPERTROPHIED HUMAN-PROSTATE [J].
AUF, G ;
GHANADIAN, R .
JOURNAL OF ENDOCRINOLOGY, 1982, 93 (03) :305-317
[2]   CHANGES IN PITUITARY-TESTICULAR SYSTEM WITH AGE [J].
BAKER, HWG ;
BURGER, HG ;
KRETSER, DMD ;
HUDSON, B ;
OCONNOR, S ;
WANG, C ;
MIROVICS, A ;
COURT, J ;
DUNLOP, M ;
RENNIE, GC .
CLINICAL ENDOCRINOLOGY, 1976, 5 (04) :349-372
[3]   INFLUENCE OF ESTRADIOL ON METABOLISM OF ANDROGENS BY HUMAN PROSTATIC TISSUE [J].
BARD, DR ;
LASNITZKI, I .
JOURNAL OF ENDOCRINOLOGY, 1977, 74 (01) :1-9
[4]  
BENSON RC, 1985, CANCER-AM CANCER SOC, V55, P382, DOI 10.1002/1097-0142(19850115)55:2<382::AID-CNCR2820550215>3.0.CO
[5]  
2-2
[6]   THE DEVELOPMENT OF HUMAN BENIGN PROSTATIC HYPERPLASIA WITH AGE [J].
BERRY, SJ ;
COFFEY, DS ;
WALSH, PC ;
EWING, LL .
JOURNAL OF UROLOGY, 1984, 132 (03) :474-479
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]   ISOLATION OF PURE AND UNALTERED LIVER NUCLEI MORPHOLOGY AND BIOCHEMICAL COMPOSITION [J].
CHAUVEAU, J ;
MOULE, Y ;
ROUILLER, C .
EXPERIMENTAL CELL RESEARCH, 1956, 11 (02) :317-321
[10]  
CHISHOLM GD, 1981, PROSTATE CANCER, P177